Carl Mauch

Investor Relations Contact chez TCR2 THERAPEUTICS INC.

Health Technology

Finance

Profil

Carl F.
Mauch is currently Director at Stern Investor Relations, Inc. since 2016.
Mr. Mauch is also Investor Relations & Media Contact at TCR² Therapeutics, Inc. Mr. Mauch will be Head-Media & Investor Relations at Vor Biopharma, Inc. starting in 2025.
Formerly, Mr. Mauch was Investor Relations & Media Contact at iTeos Therapeutics, Inc.

Postes actifs de Carl Mauch

Sociétés	Poste	Début
TCR2 THERAPEUTICS INC.	Investor Relations Contact	-
VOR BIOPHARMA INC.	Investor Relations Contact	01/01/2025
Stern Investor Relations, Inc. Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies	Directeur/Membre du Conseil	01/01/2016

Tous les postes actifs de Carl Mauch

Anciens postes connus de Carl Mauch

Sociétés	Poste	Fin
ITEOS THERAPEUTICS, INC.	Investor Relations Contact	-

Voir l'expérience en détail de Carl Mauch

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Carl Mauch

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Stern Investor Relations, Inc. Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies	Finance
TCR2 Therapeutics, Inc. TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy	Health Technology
Vor Biopharma, Inc. Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies	Health Technology
iTeos Therapeutics, Inc. iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments	Health Technology